241 related articles for article (PubMed ID: 36348337)
1. HiTIMED: hierarchical tumor immune microenvironment epigenetic deconvolution for accurate cell type resolution in the tumor microenvironment using tumor-type-specific DNA methylation data.
Zhang Z; Wiencke JK; Kelsey KT; Koestler DC; Christensen BC; Salas LA
J Transl Med; 2022 Nov; 20(1):516. PubMed ID: 36348337
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical deconvolution for extensive cell type resolution in the human brain using DNA methylation.
Zhang Z; Wiencke JK; Kelsey KT; Koestler DC; Molinaro AM; Pike SC; Karra P; Christensen BC; Salas LA
Front Neurosci; 2023; 17():1198243. PubMed ID: 37404460
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling.
Salas LA; Zhang Z; Koestler DC; Butler RA; Hansen HM; Molinaro AM; Wiencke JK; Kelsey KT; Christensen BC
Nat Commun; 2022 Feb; 13(1):761. PubMed ID: 35140201
[TBL] [Abstract][Full Text] [Related]
4. Deconvolution of immune cell composition and biological age of hepatocellular carcinoma using DNA methylation.
Jain SS; McNamara ME; Varghese RS; Ressom HW
Methods; 2023 Oct; 218():125-132. PubMed ID: 37574160
[TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation and validation of reference and library selection methods for deconvolution of cord blood DNA methylation data.
Gervin K; Salas LA; Bakulski KM; van Zelm MC; Koestler DC; Wiencke JK; Duijts L; Moll HA; Kelsey KT; Kobor MS; Lyle R; Christensen BC; Felix JF; Jones MJ
Clin Epigenetics; 2019 Aug; 11(1):125. PubMed ID: 31455416
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer.
Reynolds SR; Zhang Z; Salas LA; Christensen BC
Clin Epigenetics; 2024 Jan; 16(1):5. PubMed ID: 38173042
[TBL] [Abstract][Full Text] [Related]
7. Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz.
Scherer M; Nazarov PV; Toth R; Sahay S; Kaoma T; Maurer V; Vedeneev N; Plass C; Lengauer T; Walter J; Lutsik P
Nat Protoc; 2020 Oct; 15(10):3240-3263. PubMed ID: 32978601
[TBL] [Abstract][Full Text] [Related]
8. Deconvolution of tumor composition using partially available DNA methylation data.
He D; Chen M; Wang W; Song C; Qin Y
BMC Bioinformatics; 2022 Aug; 23(1):355. PubMed ID: 36002797
[TBL] [Abstract][Full Text] [Related]
9. A systematic assessment of cell type deconvolution algorithms for DNA methylation data.
Song J; Kuan PF
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36242584
[TBL] [Abstract][Full Text] [Related]
10. NITUMID: Nonnegative matrix factorization-based Immune-TUmor MIcroenvironment Deconvolution.
Tang D; Park S; Zhao H
Bioinformatics; 2020 Mar; 36(5):1344-1350. PubMed ID: 31593244
[TBL] [Abstract][Full Text] [Related]
11. MethylResolver-a method for deconvoluting bulk DNA methylation profiles into known and unknown cell contents.
Arneson D; Yang X; Wang K
Commun Biol; 2020 Aug; 3(1):422. PubMed ID: 32747663
[TBL] [Abstract][Full Text] [Related]
12. Cell-type deconvolution from DNA methylation: a review of recent applications.
Titus AJ; Gallimore RM; Salas LA; Christensen BC
Hum Mol Genet; 2017 Oct; 26(R2):R216-R224. PubMed ID: 28977446
[TBL] [Abstract][Full Text] [Related]
13. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications.
Zhu D; Zeng S; Su C; Li J; Xuan Y; Lin Y; Xu E; Fan Q
Clin Epigenetics; 2024 Feb; 16(1):24. PubMed ID: 38331927
[TBL] [Abstract][Full Text] [Related]
14. EMeth: An EM algorithm for cell type decomposition based on DNA methylation data.
Zhang H; Cai R; Dai J; Sun W
Sci Rep; 2021 Mar; 11(1):5717. PubMed ID: 33707472
[TBL] [Abstract][Full Text] [Related]
15. Reference-free deconvolution of DNA methylation data and mediation by cell composition effects.
Houseman EA; Kile ML; Christiani DC; Ince TA; Kelsey KT; Marsit CJ
BMC Bioinformatics; 2016 Jun; 17():259. PubMed ID: 27358049
[TBL] [Abstract][Full Text] [Related]
16. Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factors.
Hippen AA; Omran DK; Weber LM; Jung E; Drapkin R; Doherty JA; Hicks SC; Greene CS
Genome Biol; 2023 Oct; 24(1):239. PubMed ID: 37864274
[TBL] [Abstract][Full Text] [Related]
17. Deconvolution of cellular subsets in human tissue based on targeted DNA methylation analysis at individual CpG sites.
Schmidt M; Maié T; Dahl E; Costa IG; Wagner W
BMC Biol; 2020 Nov; 18(1):178. PubMed ID: 33234153
[TBL] [Abstract][Full Text] [Related]
18. Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis.
Yasumizu Y; Hagiwara M; Umezu Y; Fuji H; Iwaisako K; Asagiri M; Uemoto S; Nakamura Y; Thul S; Ueyama A; Yokoi K; Tanemura A; Nose Y; Saito T; Wada H; Kakuda M; Kohara M; Nojima S; Morii E; Doki Y; Sakaguchi S; Ohkura N
NAR Cancer; 2024 Jun; 6(2):zcae022. PubMed ID: 38751935
[TBL] [Abstract][Full Text] [Related]
19. Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumors.
Singh O; Pratt D; Aldape K
Acta Neuropathol Commun; 2021 Sep; 9(1):148. PubMed ID: 34496929
[TBL] [Abstract][Full Text] [Related]
20. Cell-type Deconvolution and Age Estimation Using DNA Methylation Reveals NK Cell Deficiency in the Hepatocellular Carcinoma Microenvironment.
Jain SS; Barefoot ME; Varghese RS; Ressom HW
Proceedings (IEEE Int Conf Bioinformatics Biomed); 2022 Dec; 2022():444-449. PubMed ID: 37663782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
